Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD (2005). Management of hepatocellular carcinoma. Hepatology 42:1208–36.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. (2012). Hepatocellular carcinoma. Lancet 379:1245–55.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. (2016). Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 32:339–44.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wu G, Sun H, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia 30:471–9.
   PubMed Web of Science ®Google Scholar
• Kuang M, Xie XY, Huang C, et al. (2011). Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg 15:2165–71.
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. (2012). A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Makuuchi M, Takayama T, et al. (2008). Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49:589–94.
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zheng Y, et al. (2006). A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–8.
   PubMed Web of Science ®Google Scholar
• Hocquelet A, Balageas P, Laurent C, et al. (2015). Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: a study of 281 Western patients. Int J Hyperthermia 31:749–57.
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Ng IO, Wong J. (2000). Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 231:544–51.
   PubMed Web of Science ®Google Scholar
• Shi M, Guo RP, Lin XJ, et al. (2007). Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kokubu S, Shibuya A, et al. (2007). Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. Am J Roentgenol 188:480–8.
   PubMed Web of Science ®Google Scholar
• Shin S, Lee JM, Kim KW, et al. (2014). Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. Am J Roentgenol 203:70–7.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Seki T, Umehara H, et al. (2007). Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy. Int J Oncol 31:485–91.
   PubMed Web of Science ®Google Scholar
• Motoyama T, Ogasawara S, Chiba T, et al. (2014). Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging 39:262–8.
   PubMedGoogle Scholar
• Sala M, Llovet JM, Vilana R, et al. (2004). Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–60.
   PubMed Web of Science ®Google Scholar
• Schraml C, Clasen S, Schwenzer NF, et al. (2008). Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 33:643–51.
   PubMedGoogle Scholar
• Koda M, Tokunaga S, Fujise Y, et al. (2012). Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol 81:1400–4.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Inuzuka T, Takeda H, et al. (2011). Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol 46:1418–26.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the Study of Liver D (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee WJ, Rhim H, et al. (2010). The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–65.
   PubMed Web of Science ®Google Scholar
• Hao Y, Numata K, Ishii T, et al. (2017). Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World J Gastroenterol 23:3111–21.
   PubMed Web of Science ®Google Scholar
• Kawamura Y, Ikeda K, Seko Y, et al. (2011). Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. Am J Roentgenol 197:W665–73.
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. (2013). Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression. Hepatol Res 43:950–8.
   PubMed Web of Science ®Google Scholar
• Bartolotta TV, Taibbi A, Matranga D, et al. (2015). 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings. Radiol Med 120:695–704.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jing X, Ding J. (2016). Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation. Clin Imaging 40:402–6.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Ikeda K, Sorin Y, et al. (2016). Three-dimensional imaging using contrast-enhanced and three-dimensional ultrasound techniques in the ablative zone treated with a multipolar radiofrequency ablation system for hepatocellular carcinoma. Oncology 90:255–60.
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang CQ, Zhang YQ, et al. (2004). Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 28:376–81.
   PubMed Web of Science ®Google Scholar